Is a complete MGRX research report available?

No complete published report is available for Mangoceuticals, Inc. (MGRX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Mangoceuticals, Inc. (MGRX)

NASDAQ: MGRX · USD

$0.56

+0.05 (+9.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MGRX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.6M
Revenue (ttm)	414.6K
Net income (ttm)	-20.4M
EPS (ttm)	-$1.56
Shares out	17.2M
Volume	491,330
Beta	2.28

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 414.6K
Net income (ttm): -20.4M
EPS (ttm): -$1.56
Market cap: 9.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MGRX indicators

Market & fundamental data

Available fields

191

Groups with data

Currency

USD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001938046
Company name	Mangoceuticals, Inc.
Country	United States
Country code	US
Cusip	56270V205
Employees	3
Employees Change	1%
Employees Change Percent	50
Enterprise value	$8.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
Industry PE Fwd	28.73
IPO Date	2023-03-21
Isin	US56270V2051
Last refreshed	2026-07-24
Market cap	$9.6M
Market cap category	Nano-Cap
Price	$0.56
Price currency	USD
Rev Per Employee	138,193x
Sector	Healthcare
Sector PE	44.54
Sector PE Fwd	23.46
Sic	8090
Symbol	MGRX
Website	https://www.mangoceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-232.35%
EV/Sales	21.45x
FCF yield	-55.71%
P/B ratio	0.64x
P/S ratio	21.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	52.42%
Gross Profit	$217,323
Gross Profit Growth	-26.24%
Gross Profit Growth Q	-53.27%
Gross Profit Growth3 Y	51.86%
Net Income	$-20.4M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-4,632.92%
Profit Per Employee	$-6.8M
ROA	-60.6
ROCE	-128
ROE	-113.9
ROIC	-64.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-65.83%
Cagr3y	-70.61%
EPS Growth Quarters	9
EPS Growth Years	2
Revenue Growth	-18.88x
Revenue Growth Q	-37.91x
Revenue Growth Years	0x
Revenue Growth3 Y	55.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$14.4M
Cash	$174,562
Current Assets	$212,472
Current Liabilities	$737,606
Debt	$294,023
Debt Equity	$0.02
Equity	$13.5M
Interest Coverage	-169.5
Liabilities	$974,571
Long Term Assets	$14.2M
Long Term Liabilities	$236,965
Net Cash	$-119,461
Net Cash By Market Cap	$-1.36
Net Debt Equity	$0.01
Tangible Book Value	$-465,059
Tangible Book Value Per Share	$-0.03
WACC	17.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.29
Net Working Capital	$-642,638
Quick ratio	0.24
Working Capital	$-525,134
Working Capital Turnover	$-0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-377.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-65.8%
200-day SMA	0.79
3Y total return	-97.46%
50-day SMA	0.4
50-day SMA vs 200-day SMA	50under200
All Time High	65.55
All Time High Change	-99.15%
All Time High Date	2023-03-21
All Time Low	0.16
All Time Low Change	244.07%
All Time Low Date	2026-03-20
ATR	0.05
Beta	2.28
Beta1y	-1.07
Beta2y	-0.75
Ch YTD	-24.68
High	0.57
High52	2.75
High52 Date	2025-10-22
High52ch	-79.73%
Low	0.53
Low52	0.16
Low52 Date	2026-03-20
Low52ch	244.07%
Ma50ch	40.4%
Premarket Change Percent	3.72
Premarket Price	$0.53
Premarket Volume	7,282
Price vs 200-day SMA	-29.01%
RSI	71.41
RSI Monthly	38.19
RSI Weekly	48.14
Sharpe ratio	0.28x
Sortino ratio	0.5
Total Return	-377.17%
Tr YTD	-24.68
Tr1m	91.55%
Tr1w	43.55%
Tr3m	23.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-17.6M
Operating margin	-4,233.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,429,530%
Float Percent	78.23%
Net Borrowing	468,500
Shares Insiders	16.15%
Shares Institutions	4.97%
Shares Out	17,167,422
Shares Qo Q	16.16%
Shares Yo Y	377.17%
Short Float	2.87%
Short Ratio	0.17
Short Shares	2.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-16.5M
Average Volume	598,553.3x
Bv Per Share	0.79
Ch1m	91.55
Ch1w	43.55
Ch1y	-65.8
Ch3m	23.87
Ch3y	-97.46
Ch6m	3.8
Change	9.08%
Change From Open	5.17
Close	0.51
Days Gap	3.72
Depreciation Amortization	1,600,799
Dollar Volume	273,867.3
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-17.6M
EBITDA	$-15.9M
EPS	$-1.56
F Score	2
FCF	$-4.9M
FCF EV Yield	-54.96x
FCF Per Share	$-0.28
Financing CF	4,985,855
Fiscal Year End	December
Founded	2,021
Ipr	-87.23
Iprfo	-99.19
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-19
Last Report Date	2026-03-31
Last Split Date	2024-10-16
Last Split Type	Reverse
Last10k Filing Date	2026-04-01
Ma150	0.46
Ma150ch	20.54%
Ma20	0.41
Ma20ch	36.22%
Net CF	98,066
Next Earnings Date	2026-08-13
Open	0.53
Optionable	No
Position In Range	71.81
Post Close	0.56
Postmarket Change Percent	0.65
Postmarket Price	$0.56
Ppne	295,605
Pre Close	0.51
Price Date	2026-07-23
Relative Volume	0.82x
Revenue	414,579x
SBC By Revenue	2,791.92x
Share Based Comp	11,574,714
Tr6m	3.8%
Us State	Texas
Volume	491,330
Z Score	1.92

Mangoceuticals, Inc. (MGRX)

Coverage state: Market snapshot only — no published research

Generate the first MGRX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · MGRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MGRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MGRX

Frequently asked questions